What's New

On July 1, Seungpyo Hong, PSD Professor, Director of Wisconsin Center for NanoBioSystems and cofounder of Capio Biosciences, will become ...

Professor Seungpyo Hong's work with Capio Biosciences is one of six faculty projects getting a boost from State Economic Engagement and D...

Capio Biosciences is pleased to announce receipt of an official Notice of Allowance for U.S. Patent Application Serial No.: 15/123,156 - ...

Capio Biosciences is pleased to announce that they have received Qualified New Business Venture (QNBV) certification from WEDC. The QNBV ...

We are very excited that Andrew Wang MD, Assoc. Prof., Dept. of Radiation Oncology, U. of North Carolina and Cofounder of Capio Bioscienc...

Capio Biosciences is pleased to be recognized by StartUpCity magazine as one of the most promising 15 Biotech startups 2019, and for bein...

Michael Poellmann presented "Quantification and downstream analysis of circulating tumor cells isolated using CapioCyte(TM) liquid biopsy...

Capio Biosciences "CapioCyte(TM) technology is featured in this article by John Gilmore of Genome web. https://www.genomeweb.com/cancer/c...

Two professors at the UW–Madison School of Pharmacy’s Pharmaceutical Sciences Division are up for the challenge of being both entrepreneu...

Seungpyo Hong presented Enhanced Sensitivity of Specificity of Circulating Tumor Cell Capture Using a Synergistic Combination of Cell Ro...